IL33 and myeloid sarcoma: Nevertheless, the above findings, together with the recent identification of ST2 expression by oligodendrocytes (Table 2) indicate an important role for IL-33/ST2 signaling pathway in the myelination process during the CNS development, and also likely the repair phase in demyelinating diseases such as MS.